Nefesh Psychiatry Llc | |
139 Executive Cir Ste 104 Daytona Beach FL 32114-7102 | |
(386) 400-3077 | |
Not Available |
Full Name | Nefesh Psychiatry Llc |
---|---|
Speciality | Clinic/Center |
Location | 139 Executive Cir Ste 104, Daytona Beach, Florida |
Authorized Official Name and Position | Zuzana Segev (PRACTICE OWNER) |
Authorized Official Contact | 3864003077 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Nefesh Psychiatry Llc 2662 Lpga Blvd # 707 Daytona Beach FL 32124-1008 Ph: (386) 400-3077 | Nefesh Psychiatry Llc 139 Executive Cir Ste 104 Daytona Beach FL 32114-7102 Ph: (386) 400-3077 |
NPI Number | 1235845744 |
---|---|
Provider Enumeration Date | 01/27/2023 |
Last Update Date | 01/27/2023 |
Certification Date | 01/27/2023 |
Medicare PECOS PAC ID | 0547632093 |
---|---|
Medicare Enrollment ID | O20230209000165 |
News Archive
Intellikine, a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, and the Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a phase I trial of INK128, a novel, orally-available small molecule kinase inhibitor of the TORC1 and TORC2 complexes, in patients with multiple myeloma.
CSL Behring announced today that the company has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for its novel recombinant fusion protein linking coagulation factor VIIa with albumin.
African American women were found to be twice as likely to be diagnosed with peripartum cardiomyopathy as compared to women of Caucasian, Hispanic/Latina, Asian, and other ethnic backgrounds, according to a new study-the largest of its kind-published today in JAMA Cardiology by researchers from the Perelman school of Medicine at the University of Pennsylvania.
Anita Iskenderian is recognized by Continental Who's Who as a Pinnacle Professional in the field of Healthcare as a result of her role as an Administrative Assistant with Magellan Health, Inc.
› Verified 9 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1235845744 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QM0850X | Clinic/center - Adult Mental Health | (* (Not Available)) | Primary |
261QM0855X | Clinic/center - Adolescent And Children Mental Health | (* (Not Available)) | Secondary |
Provider Name | Zuzana Segev |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1497155741 PECOS PAC ID: 2961623822 Enrollment ID: I20141020000519 |
News Archive
Intellikine, a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, and the Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a phase I trial of INK128, a novel, orally-available small molecule kinase inhibitor of the TORC1 and TORC2 complexes, in patients with multiple myeloma.
CSL Behring announced today that the company has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for its novel recombinant fusion protein linking coagulation factor VIIa with albumin.
African American women were found to be twice as likely to be diagnosed with peripartum cardiomyopathy as compared to women of Caucasian, Hispanic/Latina, Asian, and other ethnic backgrounds, according to a new study-the largest of its kind-published today in JAMA Cardiology by researchers from the Perelman school of Medicine at the University of Pennsylvania.
Anita Iskenderian is recognized by Continental Who's Who as a Pinnacle Professional in the field of Healthcare as a result of her role as an Administrative Assistant with Magellan Health, Inc.
› Verified 9 days ago
News Archive
Intellikine, a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, and the Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a phase I trial of INK128, a novel, orally-available small molecule kinase inhibitor of the TORC1 and TORC2 complexes, in patients with multiple myeloma.
CSL Behring announced today that the company has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for its novel recombinant fusion protein linking coagulation factor VIIa with albumin.
African American women were found to be twice as likely to be diagnosed with peripartum cardiomyopathy as compared to women of Caucasian, Hispanic/Latina, Asian, and other ethnic backgrounds, according to a new study-the largest of its kind-published today in JAMA Cardiology by researchers from the Perelman school of Medicine at the University of Pennsylvania.
Anita Iskenderian is recognized by Continental Who's Who as a Pinnacle Professional in the field of Healthcare as a result of her role as an Administrative Assistant with Magellan Health, Inc.
› Verified 9 days ago
No Place Like Aba Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 211 E International Speedway Blvd Ste 205, Daytona Beach, FL 32118 Phone: 386-271-2754 | |
Stewart Marchman Center Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3875 Tiger Bay Rd, Daytona Beach, FL 32124 Phone: 386-947-1330 | |
Newman Counseling Alternatives, P.a. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1240 Mason Ave, Daytona Beach, FL 32117 Phone: 386-253-4559 Fax: 386-253-3838 | |
Sma Healthcare Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 702 S Ridgewood Ave, Daytona Beach, FL 32114 Phone: 800-539-4228 | |
Atlantic Counseling Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 403 N Wild Olive Ave, Daytona Beach, FL 32118 Phone: 386-253-2531 Fax: 386-253-6144 | |
Sma Healthcare Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3875 Tiger Bay Rd, Daytona Beach, FL 32124 Phone: 800-539-4228 Fax: 386-236-3140 | |
Clare Kramer Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 336 Manhattan Ave, Daytona Beach, FL 32118 Phone: 407-516-1278 |